Increased serum inflammatory markers as predictors of airway obstruction

Journal of Asthma

Volumn 43, Issue 8, 2006, Pages 593-596

  De Amici, Mara ^a,b   Moratti, Remigio ^a   Quaglini, Silvana ^a   Alesina, Roberta ^a   Peona, Vittoria ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN; MYELOPEROXIDASE;

ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; CHRONIC BRONCHITIS; CLINICAL ARTICLE; EOSINOPHIL; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN TISSUE; INFLAMMATION; MALE; NEUTROPHIL CHEMOTAXIS; RETROSPECTIVE STUDY; SERUM; SMOKING; STATISTICAL ANALYSIS;

ADULT; AGED; AIRWAY RESISTANCE; BRONCHITIS; BRONCHITIS, CHRONIC; EOSINOPHIL CATIONIC PROTEIN; EOSINOPHILS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; NEUTROPHILS; ODDS RATIO; PEROXIDASE; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; SMOKING; STATISTICS; STATISTICS AS TOPIC;

EID: 33750069139     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.1080/02770900600878495     Document Type: Article

References (19)

1. Pauwels RA, Buist AS, Ma P, Jenkins CR, Hurd SS, GOLD Scientific Committee. Global Initiative. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for chronic obstructive lung disease (GOLD): executive summary. Respir Care 2001; 46:798-825.
2. Celli BR, MacNee W; ATS/ERS Task Force. Standard for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;27:242.
3. Seemungal TA, Donaldson GC, Bhowmik A, Jeffries DJ, Wedzicha JA. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 161:1608-1613.
4. Kanner RE, Anthonisen NR, Connett J; Lung Health Study Research Group. Lower respiratory illnesses promote FEV1 decline in current smokers but not ex-smokers with mild chronic obstructive lung disease: results from the lung health study. Am J Respir Crit Care Med 2001; 164:358-364.
5. Saetta M, Di Stefano A, Maestrelli P, Turato G, Ruggirei MP, Roggeri A, Calcagni P, Mapp CE, Ciacca A, Fabbri LM. Airway eosinophilia in chronic bronchitis during exacerbations. Am J Respir Crit Care 1994; 150(6 Pt. 1): 1646-1652.
6. Saetta M, Di Stefano A, Maestrelli P, Turato G, Mapp CE, Pieno M, Zanguochi G, Del Prete G, Fabbri LM; Airway eosinophilia and expression of interleukin-5 protein in asthma and in exacerbations of chronic bronchitis. Clin Exp Allergy 1996; 26:766-774.
7. Thompson AB, Daughton D, Robbins RA, Ghafouri MA, Oehlerking M, Rennard SI. Intraluminal airway inflammation in chronic bronchitis. Characterization and correlation with clinical parameters. Am Rev Respir Dis 1989; 140:1527-1537.
8. Linden M, Rasmussen JB, Piitulainen E, Tunek A, Larson M, Tegner H, Venge P, Laitinen LA, Brattsand R. Airway inflammation in smokers with nonobstructive and obstructive chronic bronchitis. Am Rev Respir Dis 1993; 148:1226-1232.
9. Ronchi MC, Pigagino C, Rosi E, Stendardi L, Galli G, Stendardi L, Tanini A, Galli G, Duranti R, Scano G. Do sputum eosinophils and ECP relate to the severity of asthma? Eur Resp J 1997; 10:1809-1813.
10. Fiorini G, Crespi S, Rinaldi M, Oberti E, Vigorelli R, Palmieri G. Serum ECP and MPO are increased during exacerbations of chronic bronchitis with airway obstruction. Biomed Pharmacother 2000; 54:274-278.
11. Levi-Schaffer F, Web VB. Mast cells, eosinophils, and fibrosis. Clin Exp Allergy 1997; 27 Suppl 1:64-70.
12. Okada S, Kita H, George TJ, Gleich GJ, Leiferman KM. Migration of eosinophils through basement membrane components in vitro: role of matrix metalloproteinase-9. Am J Respir Cell Mol Biol 1997 Oct; 17(4):519-528.
13. Levi-Schaffer F, Garbuzenco E, Rubin A, Reich R, Pickholz D, Gillery P, Emonard H, Nagler A, Maquart FA. Human eosinophils regulate human lung and skin-derived fibroblast propertis in vitro: a role for transforming growth factor beta (TGF beta). Proc Natl Acad Sci USA. 1999; 96:9660-9665.
14. Minshall EM, Leung DY, Martin RJ, Song YL, Cameron L, Ernst P, Hamid Q. Eosinophil associated TGF beta1 mRNA expression and airways fibrosis in bronchial asthma. Am J Respir Cell Mol Biol 1997; 17:326-333.
15. Dow L. Asthma versus chronic obstructive pulmonary disease-exploring why reversibility versus irreversibility is no longher an appropriate approach. Clin Exp Allergy 1999; 29:739-743.
16. Riise GC, Andersson B, Ahlstedt S, Enander I, Soderberg M, Lowhagen O, Larsson S. Bronchial brush biopsies for studies of epithelial inflammation in stable asthma and nonobstructive chronic bronchitis. Eur Respir J 1996; 9:1665-1671.
17. Spurzem JR, Thompson AB, Daughton DM, Muller M, Linder J, Rennard SI. Chronic inflammation is associated with an increased proportion of goblet cells recovered by alveolar lavage. Chest 1991; 100:389-393.
18. Martin TR, Raghu G, Maunder RJ, Sprindmeyer SC. The effects of chronic bronchits and chronic airflow obstruction on lung cell populations recovered by bronchoalveolar lavage. Am Rev Respir Dis 1985; 132:254-260.
19. Riise GC, Ahlstedt S, Larsson S, Enander I, Jones I, Larsson P, Andersson B. Bronchial inflammation in chronic bronchitis assessed by measurement of cell products in bronchial lavage fluid. Thorax 1995; 50:360-365.